8

foster.uw.edu · 2016-02-05 · Aurora Plasmonics is developing a new, cost-effective, theranostic (diagnostic and therapeutic) agent for use in non-invasive de-clotting procedures

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: foster.uw.edu · 2016-02-05 · Aurora Plasmonics is developing a new, cost-effective, theranostic (diagnostic and therapeutic) agent for use in non-invasive de-clotting procedures
Page 2: foster.uw.edu · 2016-02-05 · Aurora Plasmonics is developing a new, cost-effective, theranostic (diagnostic and therapeutic) agent for use in non-invasive de-clotting procedures
Page 3: foster.uw.edu · 2016-02-05 · Aurora Plasmonics is developing a new, cost-effective, theranostic (diagnostic and therapeutic) agent for use in non-invasive de-clotting procedures
Page 4: foster.uw.edu · 2016-02-05 · Aurora Plasmonics is developing a new, cost-effective, theranostic (diagnostic and therapeutic) agent for use in non-invasive de-clotting procedures
Page 5: foster.uw.edu · 2016-02-05 · Aurora Plasmonics is developing a new, cost-effective, theranostic (diagnostic and therapeutic) agent for use in non-invasive de-clotting procedures
Page 6: foster.uw.edu · 2016-02-05 · Aurora Plasmonics is developing a new, cost-effective, theranostic (diagnostic and therapeutic) agent for use in non-invasive de-clotting procedures
Page 7: foster.uw.edu · 2016-02-05 · Aurora Plasmonics is developing a new, cost-effective, theranostic (diagnostic and therapeutic) agent for use in non-invasive de-clotting procedures
Page 8: foster.uw.edu · 2016-02-05 · Aurora Plasmonics is developing a new, cost-effective, theranostic (diagnostic and therapeutic) agent for use in non-invasive de-clotting procedures